c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis

- Feng, Yu Chen, Liu, Xiao Ying, Teng, Liu, Ji, Qiang, Wu, Yongyan, Li, Jin Ming, Gao, Wei, Zhang, Yuan Yuan, La, Ting, Tabatabaee, Hessam, Yan, Xu Guang, Jamaluddin, M. Fairuz B., Zhang, Didi, Guo, Su Tang, Scott, Rodney J., Liu, Tao, Thorne, Rick F., Zhang, Xu Dong, Jin, Lei

Inhibition of HSP90 by AUY922 preferentially kills mutant KRAS colon cancer cells by activating Bim through ER stress

- Wang, Chun Yan, Guo, Su Tang, Wang, Jia Yu, Liu, Fen, Zhang, Yuan Yuan, Yari, Hamed, Yan, Xu Guang, Jin, Lei, Zhang, Xu Dong, Jiang, Chen Chen

BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma

- Liu, Fen, Jiang, Chen Chen, Thorne, Rick F., Jin, Lei, Wang, Qi, Zhang, Xu Dong, Yan, Xu Guang, Tseng, Hsin-Yi, Wang, Chun Yan, Zhang, Yuan Yuan, Yari, Hamed, La, Ting, Farrelly, Margaret, Guo, Su Tang

Loss of PI(4,5)P₂ 5-phosphatase A contributes to resistance of human melanoma cells to RAF/MEK inhibitors

- Ye, Yan, Li, Qun, Wang, Lai Hu, Tseng, Hsin-Yi, Jin, Lei, Zhang, Xu Dong, Zhang, Lin Jie, Yang, Sen

Reactive oxygen species dictate the apoptotic response of melanoma cells to TH588

- Wang, Jia Yu, Jin, Lei, La, Ting, McFarlane, Jennifer, Lei, Fu Xi, Tabatabaee, Hessam, Chen, Jie Zhong, Croft, Amanda, Jiang, Chen Chen, Zhang, Xu Dong, Yan, Xu Guang, Sherwin, Simonne, Farrelly, Margaret, Zhang, Yuan Yuan, Liu, Fen, Wang, Chun Yan, Guo, Su Tang, Yari, Hamed

Post translational modification-assisted cancer immunotherapy for effective breast cancer treatment

- Theivendran, Shevanuja, Tang, Jie, Lei, Chang, Yang, Yannan, Song, Hao, Gu, Zhengying, Wang, Yue, Yang, Yang, Jin, Lei, Yu, Chengzhong

Skp2-mediated stabilization of MTH1 promotes survival of melanoma cells upon oxidative stress

- Wang, Jia Yu, Liu, Guang Zhi, Jin, Lei, Wilmott, James S., La, Ting, Feng, Yu Chen, Yari, Hamed, Yan, Xu Guang, Thorne, Rick F., Scolyer, Richard A., Zhang, Xu Dong

Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells

- Liu, Yi Lun, Lai, Fritz, Jin, Lei, Zhang, Xu Dong, Wilmott, James S., Yan, Xu Guang, Liu, Xiao Ying, Luan, Qi, Guo, Su Tang, Jiang, Chen Chen, Tseng, Hsin-Yi, Scolyer, Richard A.

LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcription

- Yari, Hamed, Jin, Lei, Teng, Liu, Wang, Yufang, Wu, Yongyan, Liu, Guang Zhi, Gao, Wei, Liang, Jin, Xi, Yanfeng, Feng, Yu Chen, Zhang, Chunming, Zhang, Yuan Yuan, Tabatabaee, Hessam, La, Ting, Yang, Rui Hong, Wang, Fu Hua, Yan, Xu Guang, Farrelly, Margaret, Scott, Rodney, Liu, Tao, Thorne, Rick F., Guo, Su Tang, Zhang, Xu Dong

RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors

- Lei, Fu Xi, Jin, Lei, Liu, Xiao Ying, Lai, Fritz, Yan, Xu Guang, Farrelly, Margaret, Guo, Su Tang, Zhao, Xin Han, Zhang, Xu Dong

Towards a framework for better understanding of quiescent cancer cells

- Nabil, Wan Najbah Nik, Xi, Zhichao, Song, Zejia, Jin, Lei, Zhang, Xu Dong, Zhou, Hua, De Souza, Paul, Dong, Qihan, Xu, Hongxi

A p53-responsive miRNA network promotes cancer cell quiescence

- La, Ting, Liu, Guang Zhi, Guo, Su Tang, Liu, Tao, Thorne, Rick F., Jin, Lei, Zhang, Xu Dong, Farrelly, Margaret, Cole, Nicole, Feng, Yu Chen, Zhang, Yuan Yuan, Sherwin, Simonne K., Yari, Hamed, Tabatabaee, Hessam, Yan, Xu Guang

Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922

- Wang, Chun Yan, Guo, Su Tang, Jin, Lei, Zhang, Xu Dong, Jiang, Chen Chen, Wang, Jia Yu, Yan, Xu Guang, Farrelly, Margaret, Zhang, Yuan Yuan, Liu, Fen, Yari, Hamed, La, Ting, Lei, Fu Xi

The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis

- Teng, Liu, Feng, Yu Chen, Guo, Su Tang, Wang, Pei Lin, Qi, Teng Fei, Yue, Yi Meng, Wang, Shi Xing, Zhang, Sheng Nan, Tang, Cai Xia, La, Ting, Zhang, Yuan Yuan, Zhao, Xiao Hong, Gao, Jin Nan, Wei, Li Yuan, Zhang, Didi, Wang, Jenny Y., Shi, Yujie, Liu, Xiao Ying, Li, Jin Ming, Cao, Huixia, Thorne, Rick F., Jin, Lei, Zhang, Xu Dong

Involvement of vacuolar H⁺₋ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720

- Tay, Kwang Hong, Liu, Xiaoying, Chi, Mengna, Jin, Lei, Jiang, Chen Chen, Guo, Su Tang, Verrills, Nicole M., Tseng, Hsin-Yi, Zhang, Xu Dong

ACTN4 regulates the stability of RIPK1 in melanoma

- Zhang, Yuan Yuan, Tabataba, Hessam, Liu, Xiao Ying, Wang, Jia Yu, Yan, Xu Guang, Farrelly, Margaret, Jiang, Chen Chen, Guo, Su Tang, Liu, Tao, Kao, Hung-Ying, Thorne, Rick F., Zhang, Xu Dong, Jin, Lei

The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells

- Tseng, Hsin-Yi, Chen, Li Hua, Ye, Yan, Tay, Kwang Hong, Jiang, Chen Chen, Guo, Su Tang, Jin, Lei, Hersey, Peter, Zhang, Xu Dong

PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma

- Ye, Yan, Jin, Lei, Tay, Kwang Hong, Tseng, Hsin-Yi, Guo, Su Tang, de Bock, Charles E., Jiang, Chen Chen, Wang, Chun Yang, Wu, Mian, Zhang, Lie Jie, Hersey, Peter, Scolyer, Richard A., Wilmott, James S., Zhang, Xu Dong, Hu, Wang Lai, Yosufi, Benafsha, Thorne, Rick F., Liu, Tao, Rizos, Helen, Yan, Xu Guang, Dong, Li

Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis

- Gao, Wei, Zhang, Yuliang, Lu, Yan, Yang, Dongli, Guo, Yujia, Guo, Huina, Li, Huizheng, Zhang, Yu, Yang, Tao, Li, Li, Zhang, Linshi, Hou, Rui, Luo, Hongjie, Wen, Shuxin, An, C., Ma, T., Jin, Lei, Xu, W., Wu, Y., Niu, Min, Zheng, Xiwang, Hu, Wanglai, Cui, Jiajia, Xue, Xuting, Bo, Yunfeng, Dai, Fengsheng

BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922

- Wang, Chun Yan, Guo, Su Tang, Croft, Amanda, Yan, Xu Guang, Jin, Lei, Zhang, Xu Dong, Jiang, Chen Chen